Supplementary Table 3 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Jaume Capdevila, Oriol Arqués, José Ramón Hernández Mora, Judit Matito, Ginevra Caratù, Francesco M. Mancuso, Stefania Landolfi, Jorge Barriuso, Paula Jiménez‐Fonseca, Carlos López, Rocio García‐Carbonero, Jorge Hernando, Ignacio Matos, Nuciforo Paolo, Javier Hernández‐Losa, Manel Esteller, Anna Martínez‐Cardús, Josep Tabernero, Ana Vivancos, Héctor G. Pálmer

Dataset

Supplementary Table 1 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Jaume Capdevila, Oriol Arqués, José Ramón Hernández Mora, Judit Matito, Ginevra Caratù, Francesco M. Mancuso, Stefania Landolfi, Jorge Barriuso, Paula Jiménez‐Fonseca, Carlos López, Rocio García‐Carbonero, Jorge Hernando, Ignacio Matos, Nuciforo Paolo, Javier Hernández‐Losa, Manel Esteller, Anna Martínez‐Cardús, Josep Tabernero, Ana Vivancos, Héctor G. Pálmer

Dataset

Supplementary Table 4 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Jaume Capdevila, Oriol Arqués, José Ramón Hernández Mora, Judit Matito, Ginevra Caratù, Francesco M. Mancuso, Stefania Landolfi, Jorge Barriuso, Paula Jiménez‐Fonseca, Carlos López, Rocio García‐Carbonero, Jorge Hernando, Ignacio Matos, Nuciforo Paolo, Javier Hernández‐Losa, Manel Esteller, Anna Martínez‐Cardús, Josep Tabernero, Ana Vivancos, Héctor G. Pálmer

Dataset

Supplementary Table 2 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Jaume Capdevila, Oriol Arqués, José Ramón Hernández Mora, Judit Matito, Ginevra Caratù, Francesco M. Mancuso, Stefania Landolfi, Jorge Barriuso, Paula Jiménez‐Fonseca, Carlos López, Rocio García‐Carbonero, Jorge Hernando, Ignacio Matos, Nuciforo Paolo, Javier Hernández‐Losa, Manel Esteller, Anna Martínez‐Cardús, Josep Tabernero, Ana Vivancos, Héctor G. Pálmer

Dataset

Supplementary Table 2 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Jaume Capdevila, Oriol Arqués, José Ramón Hernández Mora, Judit Matito, Ginevra Caratù, Francesco M. Mancuso, Stefania Landolfi, Jorge Barriuso, Paula Jiménez‐Fonseca, Carlos López, Rocio García‐Carbonero, Jorge Hernando, Ignacio Matos, Nuciforo Paolo, Javier Hernández‐Losa, Manel Esteller, Anna Martínez‐Cardús, Josep Tabernero, Ana Vivancos, Héctor G. Pálmer

Supplementary Table 3 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Abstract

Discussion(0)

Related publications

Supplementary Table 3 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 1 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 4 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 2 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 2 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 3 from Epigenetic &lt;i&gt;EGFR&lt;/i&gt; Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Abstract

Discussion(0)

Related publications

Supplementary Table 3 from Epigenetic &lt;i&gt;EGFR&lt;/i&gt; Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 1 from Epigenetic &lt;i&gt;EGFR&lt;/i&gt; Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 4 from Epigenetic &lt;i&gt;EGFR&lt;/i&gt; Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 2 from Epigenetic &lt;i&gt;EGFR&lt;/i&gt; Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 2 from Epigenetic &lt;i&gt;EGFR&lt;/i&gt; Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 3 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 3 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 1 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 4 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 2 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Supplementary Table 2 from Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas